Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016


Image: A Vetter aseptically pre-filled syringe (Photo courtesy of Vetter).

German Prefilled Syringe Manufacturer to Double Production Capability

A major manufacturer of pre-filled sterile syringes, cartridges, and vials will be investing approximately EUR 300 million to expand and upgrade its manufacturing facilities over an estimated five-year period.  More...
18 Oct 2015

Sale of Mexican Pharmaceutical Company Expected to Boost Latin American Prescription Drug Market

The sale of a major Mexican pharmaceutical company to an international generic drug corporation is expected to accelerate the growth of the Latin American market for prescription drugs.  More...
11 Oct 2015

Collaboration Agreement to Boost Discovery of Fully Human Antibodies for Therapeutic Use

The discovery of fully human antibodies for therapeutic use will be boosted by a recently announced collaboration between a major university research center and a dynamic biopharmaceutical development company.  More...
04 Oct 2015

Biopharmaceutical Partners Seek Alternatives to Glucocorticoid Steroid Drugs

Collaboration between American and Japanese biopharmaceutical companies is expected to lead to the development of a new class of small molecule drugs for treatment of hematological and inflammatory diseases.  More...
28 Sep 2015

Collaboration to Promote Development of Bispecific Antibody Therapeutics for Cancer and Inflammation

Two biomedical development companies have agreed to a joint program to promote research and commercialization of bispecific monoclonal antibodies for immunotherapy of cancer and inflammation.  More...
27 Sep 2015

European Funding to Advance Development of Prostate Cancer Drug

The development of a drug for treatment of prostate cancer has been given a boost by the recent award of a EUR 2.5 million grant to its Dutch biopharmaceutical company developer.  More...
06 Sep 2015

MS Drug Deal to Net More Than USD 1 Billion

A pharmaceutical company based in Switzerland has purchased the remaining rights to the multiple sclerosis drug Ofatumumab, which will allow it to continue development of the compound for treating relapsing remitting multiple sclerosis and similar autoimmune diseases.  More...
30 Aug 2015

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2016 Globetech Media. All rights reserved.